MannKind Announces First Patient Enrolled in INHALE-1 Study of Afrezza® in Pediatric Population October 4, 2021 GlobeNewswire Source: Medical Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share